Systemic Chemokine Levels with “Gut-Specific” Vedolizumab in Patients with Inflammatory Bowel Disease—A Pilot Study

By Zwicker Stephanie   Lira-Junior Ronaldo   Höög Charlotte   Almer Sven   Boström Elisabeth A.  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-08 ,pp. : 1827-1827

MDPI

Access to resources Recommend Favorite

Urinary Metabolic Phenotyping Reveals Differences in the Metabolic Status of Healthy and Inflammatory Bowel Disease (IBD) Children in Relation to Growth and Disease Activity

By Martin Francois-Pierre   Ezri Jessica   Cominetti Ornella   Da Silva Laeticia   Kussmann Martin   Godin Jean-Philippe   Nydegger Andreas  

International Journal of Molecular Sciences, Vol. 17, Iss. 8, 2016-08 ,pp. : 1310-1310

MDPI

Access to resources Recommend Favorite

Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease

By Nie Ying   Lin Qinlu   Luo Feijun  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-06 ,pp. : 1372-1372

MDPI

Access to resources Recommend Favorite

Reduced Dendritic Cells Expressing CD200R1 in Children with Inflammatory Bowel Disease: Correlation with Th17 and Regulatory T Cells

By Elshal Mohamed F.   Aldahlawi Alia M.   Saadah Omar I.   McCoy J. Philip  

International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-12 ,pp. : 28998-29010

MDPI

Access to resources Recommend Favorite

Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease

By Klein Amir   Eliakim Rami  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. : 1084-1092

MDPI

Access to resources Recommend Favorite